Prediction of Outcomes in Crescentic IgA Nephropathy in a Multicenter Cohort Study
Authors:
Open Access
- 1 December 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 24 (12) , 2118-2125
Abstract
Crescentic IgA nephropathy (IgAN), defined as >50% crescentic glomeruli on kidney biopsy, is one of the most common causes of rapidly progressive GN. However, few studies have characterized this condition. To identify risk factors and develop a prediction model, we assessed data from patients≥14 years old with crescentic IgAN who were followed ≥12 months. The discovery cohort comprised 52 patients from one kidney center, and the validation cohort comprised 61 patients from multiple centers. At biopsy, the mean serum creatinine (SCr) level ± SD was 4.3±3.4 mg/dl, and the mean percentage of crescents was 66.4%±15.8%. The kidney survival rates at years 1, 3, and 5 after biopsy were 57.4%±4.7%, 45.8%±5.1%, and 30.4%±6.6%, respectively. Multivariate Cox regression revealed initial SCr as the only independent risk factor for ESRD (hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.10 to 1.57; P=0.002). Notably, the percentage of crescents did not associate independently with ESRD. Logistic regression showed that the risk of ESRD at 1 year after biopsy increased rapidly at SCr>2.7 mg/dl and reached 90% at SCr>6.8 mg/dl (specificity=98.5%, sensitivity=64.6% for combined cohorts). In both cohorts, patients with SCr>6.8 mg/dl were less likely to recover from dialysis. Analyses in additional cohorts revealed a similar association between initial SCr and ESRD in patients with antiglomerular basement membrane disease but not ANCA-associated systemic vasculitis. In conclusion, crescentic IgAN has a poor prognosis, and initial SCr concentration may predict kidney failure in patients with this disease.Keywords
This publication has 14 references indexed in Scilit:
- NoticeKidney International Supplements, 2012
- The Pathophysiology of IgA NephropathyJournal of the American Society of Nephrology, 2011
- Is Presence of ANCA in Crescentic IgA Nephropathy a Coincidence or Novel Clinical Entity? A Case SeriesAmerican Journal of Kidney Diseases, 2010
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibilityKidney International, 2009
- Vasculitic IgA Nephropathy: Prognosis and OutcomeNephron Clinical Practice, 2009
- Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal VasculitisJournal of the American Society of Nephrology, 2007
- IgA NephropathyJournal of the American Society of Nephrology, 2005
- Idiopathic IgA Nephropathy with Diffuse Crescent FormationAmerican Journal of Nephrology, 2002
- Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroupsKidney International, 2002
- Therapy of Anti-Glomerular Basement Membrane Antibody DiseaseMedicine, 1985